JNJ
JNJ jumped 3.3 percent today — a meaningful lift for a stock that doesn't normally move like a growth name — and with nothing company-specific in the news, this looks like sector rotation into defensive healthcare. What the tape does give us is an insider filing: executive Jennifer Taubert disclosed a 2.2 million dollar net share sale. Before you read bearish intent into that, understand how 10b5-1 plans work. Large-cap executives pre-schedule their trades months in advance through these SEC-approved programs — so the execution date has nothing to do with their current view on the stock. The sale is background noise here. Watch for any talc litigation development or pipeline update from JNJ; if either hits, this rotation move could find a narrative to stick with.
-2.2% — Moved with the tape — no single reported reason that day.
+3.3% — Moved with the tape — no single reported reason that day.
-3.7% — Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is
+1.6% — FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System
+2.0% — FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System
-1.7% — Top Analyst Reports for Johnson & Johnson, Lam Research & Seagate
-2.7% — Johnson & Johnson (JNJ) Q2 2026 Earnings Call Highlights: Strong Sales Growth and Raised ...
-1.5% — Moved with the tape — no single reported reason that day.
-1.6% — Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
+3.1% — Johnson & Johnson (JNJ) Could Be 34% Below Fair Value Following IMAAVY Update
+3.6% — JNJ Stock Management Sees A Breakout, The Market Sees A Standoff
-1.8% — Why Is JNJ Stock Defying The Market’s Daily Mood Swings?
+1.5% — Moved with the tape — no single reported reason that day.
+4.0% — Johnson & Johnson (JNJ) Unveils IMAAVY Data That Could Expand Early gMG Use
+1.6% — Johnson & Johnson Earnings Preview: What to Expect
+3.4% — Moved with the tape — no single reported reason that day.
-2.5% — Moved with the tape — no single reported reason that day.
-2.2% — Moved with the tape — no single reported reason that day.
+2.1% — Moved with the tape — no single reported reason that day.
+2.0% — Moved with the tape — no single reported reason that day.
+2.2% — Moved with the tape — no single reported reason that day.
-2.4% — Moved with the tape — no single reported reason that day.
-1.8% — Assessing Johnson & Johnson (JNJ) Valuation After Guidance Raise Growth Initiatives And Talc Litigation Update
The brief, in your inbox
One email every market morning. What moved, why, and what happened after.